article thumbnail

2022: The Year to Build Supply Chain Resiliency

ProcurePort

Global supply chains have suffered immensely in the last two years due to the COVID-19 pandemic. There has been a shortage of materials, shipping prices have gone up, and ports have been backed up. This has in turn affected global commodity prices leading to a discussion about […].

article thumbnail

Inflation + Source-to-Pay Strategies: The Cure for the Common Price Hike

ivalua

Inflationary pressures can cause frustration levels among suppliers due to increased costs or reduced demand from customers, particularly when it comes to repeated orders or fixed pricing contracts. This could include negotiating more favorable terms with suppliers or renegotiating existing contracts to ensure that prices remain competitive.

Price 264
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ivalua Launches Collaboration and AI-Powered Innovations to Help Organizations Improve Supply Chain Resilience and Profitability

ivalua

This will free up more valuable time for users to manage critical issues around supply disruption, price volatility, as well as environmental, social, and governance risks.”. “Our new release will further boost collaboration and greatly enhance automation and efficiency. About Ivalua. Lumina Communications for Ivalua. 212-239-8594.

article thumbnail

Let’s approach supply chain resilience holistically

HICX

By Costas Xyloyiannis, co-founder and CEO of HICX While inflation and economic pressures, such as the recent US price reforms, force pharmaceutical brands to be even more frugal than usual, they will do well to not tackle cost efficiency as a solo issue. Brands require resilience in various areas, and chief among these is compliance.

article thumbnail

How Pharmaceutical Brands can be Resilient: Let’s approach Supply Chain Resilience Holistically

HICX

By Costas Xyloyiannis, CEO of HICX While inflation and economic pressures, such as the recent US price reforms, force pharmaceutical brands to be even more frugal than usual, they will do well to not tackle cost efficiency as a solo issue. Brands require resilience in various areas, and chief among these is compliance.

article thumbnail

Maersk abandons $1B sale of container business after DOJ investigation

Supply Chain Dive

Regulators were concerned that a sale to China International Marine Containers would have led to higher prices and less supply chain resiliency.

article thumbnail

Procurement Rising: The Silent Inflation Tax on Manufacturers

ivalua

Ivalua Spend Management Insights [ivory-search] Procurement Rising: The Silent Inflation Tax on Manufacturers February 27, 2023 | | Manufacturing by Doug Keeley Last year, the Consumer Price Index was the highest it has been in four decades, making inflation one of the most concerning macroeconomic factors facing the business world today.